GSK Plc (GSK)
50.50
-0.03
(-0.06%)
USD |
NYSE |
May 07, 16:00
50.38
-0.12
(-0.24%)
Pre-Market: 08:27
GSK Research and Development Expense (Annual) : 8.171B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| AstraZeneca PLC | 13.84B |
| Amgen, Inc. | 6.974B |
| Novavax, Inc. | 336.82M |
| BioNTech SE | 2.376B |
| Moderna, Inc. | 2.917B |